The DOI matches its Crossref record; 34 of the 34 references it cites were found in a registry or an index.
Myostatin, a Negative Regulator of Muscle Growth, Functions by Inhibiting Myoblast Proliferation
Open accessAbstract
Myostatin, a member of the transforming growth factor-beta (TGF-beta) superfamily, has been shown to be a negative regulator of myogenesis. Here we show that myostatin functions by controlling the proliferation of muscle precursor cells. When C(2)C(12) myoblasts were incubated with myostatin, proliferation of myoblasts decreased with increasing levels of myostatin. Fluorescence-activated cell sorting analysis revealed that myostatin prevented the progression of myoblasts from the G(1)- to S-phase of the cell cycle. Western analysis indicated that myostatin specifically up-regulated p21(Waf1, Cip1), a cyclin-dependent kinase inhibitor, and decreased the levels and activity of Cdk2 protein in myoblasts. Furthermore, we also observed that in myoblasts treated with myostatin protein, Rb was predominately present in the hypophosphorylated form. These results suggests that, in response to myostatin signaling, there is an increase in p21 expression and a decrease in Cdk2 protein and activity thus resulting in an accumulation of hypophosphorylated Rb protein. This, in turn, leads to the arrest of myoblasts in G(1)-phase of cell cycle. Thus, we propose that the generalized muscular hyperplasia phenotype observed in animals that lack functional myostatin could be as a result of deregulated myoblast proliferation.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Myostatin is a cytokine that works by inhibiting the proliferation of satellite cells and the differentiation of myoblasts [10], while also decreasing adipogenesis via reductions in the secretion of leptin [11].”
From Effects of methoxyisoflavone, ecdysterone, and sulfo-polysaccharide supplementation on training adaptations in resistance-trained males (2006) · cites this paper as [10]
Citations
Cites
CDK inhibitors: positive and negative regulators of G1-phase progression
Sherr, C. J., & Roberts, J. M. (1999) · Genes & Development · doi:10.1101/gad.13.12.1501 · Cited by 6,115
Regulation of skeletal muscle mass in mice by a new TGF-p superfamily member
McPherron, A. C., Lawler, A. M., & Lee, S.-J. (1997) · Nature · doi:10.1038/387083a0 · Cited by 4,013
Inhibitors of mammalian G1 cyclin-dependent kinases.
Sherr, C. J., & Roberts, J. M. (1995) · Genes & Development · doi:10.1101/gad.9.10.1149 · Cited by 3,243
G1 phase progression: Cycling on cue
Sherr, C. J. (1994) · Cell · doi:10.1016/0092-8674(94)90540-1 · Cited by 2,674
Serial passaging and differentiation of myogenic cells isolated from dystrophic mouse muscle
YAFFE, D., & SAXEL, O. (1977) · Nature · doi:10.1038/270725a0 · Cited by 2,123
Double muscling in cattle due to mutations in the myostatin gene
McPherron, A. C., & Lee, S.-J. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.23.12457 · Cited by 2,039
pl5INK4B is a potentia| effector of TGF-β-induced cell cycle arrest
Hannon, G. J., & Beach, D. (1994) · Nature · doi:10.1038/371257a0 · Cited by 1,950
MyoD or Myf-5 is required for the formation of skeletal muscle
Rudnicki, M. A., Schnegelsberg, P. N. J., Stead, R. H., Braun, T., Arnold, H.-H., & Jaenisch, R. (1993) · Cell · doi:10.1016/0092-8674(93)90621-v · Cited by 1,731
A deletion in the bovine myostatin gene causes the double–muscled phenotype in cattle
Grobet, L., Royo Martin, L. J., Poncelet, D., Pirottin, D., Brouwers, B., Riquet, J., Schoeberlein, A., Dunner, S., Ménissier, F., Massabanda, J., et al. (1997) · Nature Genetics · doi:10.1038/ng0997-71 · Cited by 1,556
New functional activities for the p21 family of CDK inhibitors.
LaBaer, J., Garrett, M. D., Stevenson, L. F., Slingerland, J. M., Sandhu, C., Chou, H. S., Fattaey, A., & Harlow, E. (1997) · Genes & Development · doi:10.1101/gad.11.7.847 · Cited by 1,402
Research works printed but not linked: 1
- Ji, 1998, Am. J. Physiol., 275(4 Pt 2),, R1265
Cited by
Cellular and Molecular Regulation of Muscle Regeneration
CHARGÉ, S. B. P., & RUDNICKI, M. A. (2004) · Physiological Reviews · doi:10.1152/physrev.00019.2003 · Cited by 2,680
“Furthermore, recent in vitro experiments demonstrated that at high levels, MSTN inhibits proliferation and affects differentiation of C2C12, via cyclin-Cdk2 inactivation of retinoblastoma protein (Rb) (253, 254, 309, 313).”
BackgroundMyostatin Inhibits Myoblast Differentiation by Down-regulating MyoD Expression
Langley, B., Thomas, M., Bishop, A., Sharma, M., Gilmour, S., & Kambadur, R. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m204291200 · Cited by 908
Self-citationInduction of Cachexia in Mice by Systemically Administered Myostatin
Zimmers, T. A., Davies, M. V., Koniaris, L. G., Haynes, P., Esquela, A. F., Tomkinson, K. N., McPherron, A. C., Wolfman, N. M., & Lee, S.-J. (2002) · Science · doi:10.1126/science.1069525 · Cited by 907
Mosher, D. S., Quignon, P., Bustamante, C. D., Sutter, N. B., Mellersh, C. S., Parker, H. G., & Ostrander, E. A. (2007) · PLoS Genetics · doi:10.1371/journal.pgen.0030079 · Cited by 826
“therefore controls the total number of muscle fibers by regulating overall myoblast proliferation [”
BackgroundREGULATION OF MUSCLE MASS BY MYOSTATIN
Lee, S.-J. (2004) · Annual Review of Cell and Developmental Biology · doi:10.1146/annurev.cellbio.20.012103.135836 · Cited by 819
Myostatin negatively regulates satellite cell activation and self-renewal
McCroskery, S., Thomas, M., Maxwell, L., Sharma, M., & Kambadur, R. (2003) · The Journal of Cell Biology · doi:10.1083/jcb.200207056 · Cited by 784
“Primary and secondary myoblasts that lack Myostatin proliferate faster Previously, we have shown that high concentrations of Myostatin inhibit the proliferation of myoblasts by controlling the G 1 to S transition during cell cycle (Thomas et al., 2000).”
BackgroundMethodResultSelf-citationEffects of Resistance Training on Older Adults
Hunter, G. R., McCarthy, J. P., & Bamman, M. M. (2004) · Sports Medicine · doi:10.2165/00007256-200434050-00005 · Cited by 764
The Molecular Bases of Training Adaptation
Coffey, V. G., & Hawley, J. A. (2007) · Sports Medicine · doi:10.2165/00007256-200737090-00001 · Cited by 756
Glucocorticoid-Induced Skeletal Muscle Atrophy
Schakman, O., Kalista, S., Barbé, C., Loumaye, A., & Thissen, J. P. (2013) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2013.05.036 · Cited by 705
Skeletal muscle: A review of molecular structure and function, in health and disease
Mukund, K., & Subramaniam, S. (2020) · WIREs Systems Biology and Medicine · doi:10.1002/wsbm.1462 · Cited by 664
Mechanisms of glucocorticoid-induced myopathy
Schakman, O., Gilson, H., & Thissen, J. P. (2008) · Journal of Endocrinology · doi:10.1677/joe-07-0606 · Cited by 521
“…Ma et al. 2001, 2003, Artaza et al. 2002), a growth factor that inhibits the muscle mass development by downregulating the proliferation, and differentiation of satellite cells (Thomas et al. 2000, McCroskery et al. 2003) and downregulating protein synthesis (Taylor et al. 2001, Welle et al. 2006).”
BackgroundMolecular Signature of Quiescent Satellite Cells in Adult Skeletal Muscle
Fukada, S.-I., Uezumi, A., Ikemoto, M., Masuda, S., Segawa, M., Tanimura, N., Yamamoto, H., Miyagoe-Suzuki, Y., & Takeda, S. (2007) · Stem Cells · doi:10.1634/stemcells.2007-0019 · Cited by 506
Divergence and convergence of TGF‐β/BMP signaling
Miyazono, K., Kusanagi, K., & Inoue, H. (2001) · Journal of Cellular Physiology · doi:10.1002/jcp.1080 · Cited by 505
“…et al., 1994; Pece-Barbara et al., 1999); ALK-1 (Johnson et al., 1996; Abdalla et al., 2000); BMPR-II (Deng et al., 2000; Lane et al., 2000; Thomson et al., 2000); TGIF (Gripp et al., 2000); CBP (Petrij et al., 1995; Borrow et al., 1996; Taki et al., 1997); p300 (Ida et al., 1997); Evi-1…”
Inhibition of myostatin in adult mice increases skeletal muscle mass and strength
Whittemore, L.-A., Song, K., Li, X., Aghajanian, J., Davies, M., Girgenrath, S., Hill, J. J., Jalenak, M., Kelley, P., Knight, A., et al. (2003) · Biochemical and Biophysical Research Communications · doi:10.1016/s0006-291x(02)02953-4 · Cited by 503
Marblestone, J. G., Edavettal, S. C., Lim, Y., Lim, P., Zuo, X., & Butt, T. R. (2006) · Protein Science · doi:10.1110/ps.051812706 · Cited by 487
“coli have been hampered by poor yields, solubility, and lack of biological activity, and therefore, GDF8 is considered to be a difficult-to-express protein (Thomas et al. 2000; Taylor et al. 2001).”
BackgroundMcFarlane, C., Plummer, E., Thomas, M., Hennebry, A., Ashby, M., Ling, N., Smith, H., Sharma, M., & Kambadur, R. (2006) · Journal of Cellular Physiology · doi:10.1002/jcp.20757 · Cited by 480
“During prenatal development Myostatin appears to function by negatively regulating myoblast proliferation via control of the G1 to S transition of the cell-cycle through both Retinoblastoma-dependent and -independent mechanisms (Thomas et al., 2000; Langley et al., 2004).”
BackgroundSelf-citationLouis, E., Raue, U., Yang, Y., Jemiolo, B., & Trappe, S. (2007) · Journal of Applied Physiology · doi:10.1152/japplphysiol.00679.2007 · Cited by 478
“Myostatin is a member of the transforming growth factorgene family and has been shown to be a negative regulator of muscle growth (33, 53).”
Muscle-specific expression of insulin-like growth factor I counters muscle decline in mdx mice
Barton, E. R., Morris, L., Musaro, A., Rosenthal, N., & Sweeney, H. L. (2002) · The Journal of Cell Biology · doi:10.1083/jcb.200108071 · Cited by 451
“Myostatin has been shown to block myoblast proliferation in vitro (Thomas et al., 2000), whereas HGF and fibroblast growth factor are involved in the activation and proliferation of satellite cells (Sheehan and Allen, 1999).”
BackgroundHill, J. J., Davies, M. V., Pearson, A. A., Wang, J. H., Hewick, R. M., Wolfman, N. M., & Qiu, Y. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m206379200 · Cited by 443
Muscle wasting and cachexia in heart failure: mechanisms and therapies
von Haehling, S., Ebner, N., dos Santos, M. R., Springer, J., & Anker, S. D. (2017) · Nature Reviews Cardiology · doi:10.1038/nrcardio.2017.51 · Cited by 421
Wagers, A. J., & Conboy, I. M. (2005) · Cell · doi:10.1016/j.cell.2005.08.021 · Cited by 421
“On the other end of the proliferative spectrum, the muscle-specific TGF-β family member, GDF8, inhibits cell-cycle progression in myogenic progenitors during embryonic development and in adult muscle via induction of p21 and suppression of the cyclin-dependent kinase CDK25 (McCroskery et al., 2003; McPherron et al., 1…”
BackgroundMa, K., Mallidis, C., Bhasin, S., Mahabadi, V., Artaza, J., Gonzalez-Cadavid, N., Arias, J., & Salehian, B. (2003) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00487.2002 · Cited by 414
“Our previous in vitro observations that recombinant myostatin protein inhibits muscle cell proliferation and protein synthesis (36, 37, 44, 45) suggest that it may have an antianabolic effect.”
Tissue-Specific Stem Cells: Lessons from the Skeletal Muscle Satellite Cell
Brack, A. S., & Rando, T. A. (2012) · Cell Stem Cell · doi:10.1016/j.stem.2012.04.001 · Cited by 413
“…TGF-β family member, GDF8, inhibits cell-cycle progression in myogenic progenitors during embryonic development and in adult muscle via induction of p21 and suppression of the cyclin-dependent kinase CDK25 (McCroskery et al., 2003; McPherron et al., 1997; Thomas et al., 2000; Zimmers et al., 2002).”
BackgroundFollistatin complexes Myostatin and antagonises Myostatin-mediated inhibition of myogenesis
Amthor, H., Nicholas, G., McKinnell, I., Kemp, C. F., Sharma, M., Kambadur, R., & Patel, K. (2004) · Developmental Biology · doi:10.1016/j.ydbio.2004.01.046 · Cited by 401
Self-citationControl of the size of the human muscle mass
Rennie, M. J., Wackerhage, H., Spangenburg, E. E., & Booth, F. W. (2004) · Annual Review of Physiology · doi:10.1146/annurev.physiol.66.052102.134444 · Cited by 399
Myostatin and the skeletal muscle atrophy and hypertrophy signaling pathways
Rodriguez, J., Vernus, B., Chelh, I., Cassar-Malek, I., Gabillard, J. C., Hadj Sassi, A., Seiliez, I., Picard, B., & Bonnieu, A. (2014) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-014-1689-x · Cited by 397
“Myostatin anti-proliferative action is associated with up-regulation of p21 (cyclin-dependent kinase inhibitor) and the subsequent decrease of cyclindependent kinases (CDK2 and CDK4) and phosphorylated retinoblastoma protein (RB) levels [52, 59, 61] (Fig.”
BackgroundEnvironment and plasticity of myogenesis in teleost fish
Johnston, I. A. (2006) · Journal of Experimental Biology · doi:10.1242/jeb.02153 · Cited by 382
“It has been reported that myostatin inhibits myoblast proliferation by upregulating p21Waf1,Cip1 and downregulating cyclin-E-Cdk2 activity (Thomas et al., 2000) and activates myoblast differentiation by downregulating the expression of MyoD, Myf5 and Pax-3 (Yang et al., 2005).”
BackgroundSatellite cells in human skeletal muscle plasticity
Snijders, T., Nederveen, J. P., McKay, B. R., Joanisse, S., Verdijk, L. B., van Loon, L. J. C., & Parise, G. (2015) · Frontiers in Physiology · doi:10.3389/fphys.2015.00283 · Cited by 359
“In vitro experiments have shown that myostatin blocks myoblast proliferation (Thomas et al., 2000; Taylor et al., 2001) and differentiation by the down regulation of MyoD (Langley et al., 2002) and up-regulation of p21, a regulator of cell cycle progression (McFarlane et al., 2011).”
BackgroundGene expression profile of aging in human muscle
Welle, S., Brooks, A. I., Delehanty, J. M., Needler, N., & Thornton, C. A. (2003) · Physiological Genomics · doi:10.1152/physiolgenomics.00049.2003 · Cited by 353
“Myostatin overexpression induces expression of cyclin-dependent kinase inhibitor 1A, also known as p21, and suppresses expression of cyclin-dependent kinase 2 (cdk2) (32, 45).”
BackgroundMechanisms involved in the inhibition of myoblast proliferation and differentiation by myostatin
Joulia, D., Bernardi, H., Garandel, V., Rabenoelina, F., Vernus, B., & Cabello, G. (2003) · Experimental Cell Research · doi:10.1016/s0014-4827(03)00074-0 · Cited by 337
Autoregulation of Neurogenesis by GDF11
Wu, H.-H., Ivkovic, S., Murray, R. C., Jaramillo, S., Lyons, K. M., Johnson, J. E., & Calof, A. L. (2003) · Neuron · doi:10.1016/s0896-6273(02)01172-8 · Cited by 337
“The OE is one of the few regions of the mammalian pression of p21Cip1/Waf1 (Thomas et al., 2000), a homolog of p27Kip1 that acts similarly to cause cell cycle arrest.nervous system with the capacity for true neuronal re- generation, and the action of GDF11 on INPs may be of Interestingly, such…”
BackgroundMethodInfluentialReza, M. M., Subramaniyam, N., Sim, C. M., Ge, X., Sathiakumar, D., McFarlane, C., Sharma, M., & Kambadur, R. (2017) · Nature Communications · doi:10.1038/s41467-017-01131-0 · Cited by 335
Self-citationLower skeletal muscle mass in male transgenic mice with muscle-specific overexpression of myostatin
Reisz-Porszasz, S., Bhasin, S., Artaza, J. N., Shen, R., Sinha-Hikim, I., Hogue, A., Fielder, T. J., & Gonzalez-Cadavid, N. F. (2003) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00107.2003 · Cited by 333
“However, previous studies by our group (39) and others (29, 40) suggest that myostatin inhibits muscle cell replication by restraining the entry of myoblasts into the cell cycle.”
ResultIncreased secretion and expression of myostatin in skeletal muscle from extremely obese women
Hittel, D. S., Berggren, J. R., Shearer, J., Boyle, K., & Houmard, J. A. (2009) · Diabetes · doi:10.2337/db08-0943 · Cited by 324
“These observations are consistent with previous studies of the growth-inhibiting effects of myostatin on myoblast proliferation (18,19,22).”
BackgroundMethodResultInfluentialMyostatin is an inhibitor of myogenic differentiation
Rı́os, R., Carneiro, I., Arce, V. M., & Devesa, J. (2002) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00372.2001 · Cited by 323
“Recombinant MSTN has been shown to reversibly inhibit C2C12 murine myoblast proliferation by arresting cells in the G1 and G2/M stages of the cell cycle (29).”
BackgroundShan, T., Liang, X., Bi, P., & Kuang, S. (2013) · The FASEB Journal · doi:10.1096/fj.12-225755 · Cited by 301
Qiu, J., Thapaliya, S., Runkana, A., Yang, Y., Tsien, C., Mohan, M. L., Narayanan, A., Eghtesad, B., Mozdziak, P. E., McDonald, C., et al. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1317049110 · Cited by 292
“Even though the mechanisms of regulation of skeletal muscle mass by myostatin has been extensively studied (14, 34), there is very limited data on the upstream modulators of myostatin (35, 36).”
BackgroundMicroRNAs in skeletal muscle: Their role and regulation in development, disease and function
Güller, I., & Russell, A. P. (2010) · The Journal of Physiology · doi:10.1113/jphysiol.2010.194175 · Cited by 290
“The enhanced muscular development of the Texel sheep has been mapped to a single G-A mutation in the 3′-UTR of the myostatin gene, a gene involved in the repression of muscle growth (Thomas et al. 2000; McFarlane et al. 2006).”
BackgroundClinical relevance of sarcopenia in chronic kidney disease
Moorthi, R. N., & Avin, K. G. (2017) · Current Opinion in Nephrology and Hypertension · doi:10.1097/mnh.0000000000000318 · Cited by 269
Myostatin decreases with aerobic exercise and associates with insulin resistance
HITTEL, D. S., AXELSON, M., SARNA, N., SHEARER, J., HUFFMAN, K. M., & KRAUS, W. E. (2010) · Medicine & Science in Sports & Exercise · doi:10.1249/mss.0b013e3181e0b9a8 · Cited by 271
“Mature MSTN is then secreted from muscle so it can act locally or systemically via the activin type IIA and type IIB receptors (29,34).”
BackgroundRelationships between Transforming Growth Factor-β1, Myostatin, and Decorin
Zhu, J., Li, Y., Shen, W., Qiao, C., Ambrosio, F., Lavasani, M., Nozaki, M., Branca, M. F., & Huard, J. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m704146200 · Cited by 269
Allen, D. L., & Unterman, T. G. (2007) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00542.2005 · Cited by 229
Myostatin Directly Regulates Skeletal Muscle Fibrosis
Li, Z. B., Kollias, H. D., & Wagner, K. R. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m802585200 · Cited by 262
Kim, J.-S., Cross, J. M., & Bamman, M. M. (2005) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00464.2004 · Cited by 260
“Myostatin impairs muscle growth by inhibiting myoblast proliferation (36, 37) as well as differentiation (21, 30) in developing muscle.”
BackgroundDirks, M. L., Wall, B. T., Snijders, T., Ottenbros, C. L. P., Verdijk, L. B., & van Loon, L. J. C. (2014) · Acta Physiologica · doi:10.1111/apha.12200 · Cited by 251
Gilson, H., Schakman, O., Kalista, S., Lause, P., Tsuchida, K., & Thissen, J.-P. (2009) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00193.2009 · Cited by 248
The impact of sarcopenia and exercise training on skeletal muscle satellite cells
Snijders, T., Verdijk, L. B., & van Loon, L. J. C. (2009) · Ageing Research Reviews · doi:10.1016/j.arr.2009.05.003 · Cited by 246
“In addition, follistatin has been shown to inhibit myostatin, a negative regulator of myogenesis (Amthor et al., 2007; Lee and McPherron, 2001; Matsakas and Diel, 2005; Thomas et al., 2000).”
BackgroundCiarmela, P., Islam, M. S., Reis, F. M., Gray, P. C., Bloise, E., Petraglia, F., Vale, W., & Castellucci, M. (2011) · Human Reproduction Update · doi:10.1093/humupd/dmr031 · Cited by 244
“Using a range of myostatin doses, it was revealed that the inhibition of growth of PHM1 cells was dose-dependent, with an EC50 of 1.1 nM, comparable with other systems reported myostatin responses (Thomas et al., 2000; Ciarmela et al., 2009).”
BackgroundResultInfluentialThe effects of obesity on skeletal muscle regeneration
Akhmedov, D., & Berdeaux, R. (2013) · Frontiers in Physiology · doi:10.3389/fphys.2013.00371 · Cited by 241
“…C2C12 myoblasts, recombinant or overexpressed myostatin decreases proliferation most likely by stimulating expression of the cyclin-dependent kinase inhibitor p21, resulting in inhibition of Cdk2 and impaired G1 to S phase transition (Thomas et al., 2000; Taylor et al., 2001; Joulia et al., 2003).”
BackgroundClinical, Agricultural, and Evolutionary Biology of Myostatin: A Comparative Review
Rodgers, B. D., & Garikipati, D. K. (2008) · Endocrine Reviews · doi:10.1210/er.2008-0003 · Cited by 237
“Recombinants from both systems inhibit myoblast proliferation in vitro; however, those generated in bacteria are functionally active only at very high concentrations (2–10 g/ml, 100–500 m) (59, 61, 63, 65, 69, 70).”
BackgroundMyostatin Inhibits IGF-I-Induced Myotube Hypertrophy through Akt
Morissette, M. R., Cook, S. A., Buranasombati, C., Rosenberg, M. A., & Rosenzweig, A. (2009) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00043.2009 · Cited by 231
“during development, have been reported (9, 12, 34).”
BackgroundDEBIGARÉ, R., CÔTÉ, C. H., & MALTAIS, F. (2001) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.164.9.2104035 · Cited by 231
Girgenrath, S., Song, K., & Whittemore, L.-A. (2005) · Muscle & Nerve · doi:10.1002/mus.20175 · Cited by 228
Pharmacological strategies for muscular dystrophy
Khurana, T. S., & Davies, K. E. (2003) · Nature Reviews Drug Discovery · doi:10.1038/nrd1085 · Cited by 225
Effects of spaceflight on murine skeletal muscle gene expression
Allen, D. L., Bandstra, E. R., Harrison, B. C., Thorng, S., Stodieck, L. S., Kostenuik, P. J., Morony, S., Lacey, D. L., Hammond, T. G., Leinwand, L. L., et al. (2009) · Journal of Applied Physiology · doi:10.1152/japplphysiol.90780.2008 · Cited by 224
“Myostatin acts in a paracrine/autocrine loop by binding to members of the activin RII receptor family, most notably ActRIIb (19), and decreases myoblast proliferation (42), differentiation (18, 33), and protein synthesis (40) while increasing expression of protein”
BackgroundResultHill, J. J., Qiu, Y., Hewick, R. M., & Wolfman, N. M. (2003) · Molecular Endocrinology · doi:10.1210/me.2002-0366 · Cited by 225
“inducing cell cycle arrest in the G1 phase (7, 8).”
BackgroundWaters, D. (2010) · Clinical Interventions in Aging · doi:10.2147/cia.s6920 · Cited by 220
“superfamily and is known to be a negative regulator of skeletal muscle myogenesis.(148,149) The primary action of myostatin”
Yang, W., Zhang, Y., Li, Y., Wu, Z., & Zhu, D. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m610185200 · Cited by 218
Improved muscle healing through enhanced regeneration and reduced fibrosis in myostatin-null mice
McCroskery, S., Thomas, M., Platt, L., Hennebry, A., Nishimura, T., McLeay, L., Sharma, M., & Kambadur, R. (2005) · Journal of Cell Science · doi:10.1242/jcs.02482 · Cited by 214
“Fibers were left to attach for 3 minutes, then 500 μl of fiber media [FM; DMEM, 10% (v/v) horse serum (HS), 0.5% (v/v) chick embryo extract (CEE), (penicillin/streptomycin)] or FM with increasing amounts of recombinant Mstn (Thomas et al., 2000) was added.”
BackgroundMethodSelf-citationExpression and function of myostatin in obesity, diabetes, and exercise adaptation
ALLEN, D. L., HITTEL, D. S., & MCPHERRON, A. C. (2011) · Medicine & Science in Sports & Exercise · doi:10.1249/mss.0b013e3182178bb4 · Cited by 207
“Regardless of the pathway, myostatin inhibits muscle stem cell proliferation (61,62) and differentiation (29) BASIC SCIENCES”
Dominique, J.-E., & Gérard, C. (2006) · Experimental Cell Research · doi:10.1016/j.yexcr.2006.04.012 · Cited by 207
Raue, U., Slivka, D., Jemiolo, B., Hollon, C., & Trappe, S. (2006) · Journal of Applied Physiology · doi:10.1152/japplphysiol.01616.2005 · Cited by 204
“Myostatin, a member of the transforming growth factorsuperfamily, is well known as a negative regulator of myogenesis, and has been shown to control the proliferation of muscle precursor cells (39).”
BackgroundAnalysis of myostatin gene structure, expression and function in zebrafish
Xu, C., Wu, G., Zohar, Y., & Du, S.-J. (2003) · Journal of Experimental Biology · doi:10.1242/jeb.00635 · Cited by 203
“The bioactive C-terminal domain dimerizes and binds to membrane receptors on target cells (Thomas et al., 2000).”
BackgroundInfluentialKovacheva, E. L., Sinha Hikim, A. P., Shen, R., Sinha, I., & Sinha-Hikim, I. (2010) · Endocrinology · doi:10.1210/en.2009-1177 · Cited by 197
“It is also possible that suppression of JNK could activate cellular proliferation and, in turn, muscle growth by attenuating myostatin-induced up-regulation of p21 (40, 60), a potent inhibitor of various CDK activities (61).”
BackgroundDubois, V., Laurent, M., Boonen, S., Vanderschueren, D., & Claessens, F. (2012) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-011-0883-3 · Cited by 197
Decorin binds myostatin and modulates its activity to muscle cells
Miura, T., Kishioka, Y., Wakamatsu, J.-I., Hattori, A., Hennebry, A., Berry, C. J., Sharma, M., Kambadur, R., & Nishimura, T. (2006) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2005.12.060 · Cited by 198
Self-citationInhibition of myostatin with emphasis on follistatin as a therapy for muscle disease
Rodino‐Klapac, L. R., Haidet, A. M., Kota, J., Handy, C., Kaspar, B. K., & Mendell, J. R. (2009) · Muscle & Nerve · doi:10.1002/mus.21244 · Cited by 194
Hennebry, A., Berry, C., Siriett, V., O'Callaghan, P., Chau, L., Watson, T., Sharma, M., & Kambadur, R. (2009) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00259.2007 · Cited by 193
“We have previously shown that inactivation of Mstn leads to hyperplasia by increasing the myoblast number possibly during embryonic and or fetal myogenesis (38).”
BackgroundMethodSelf-citationTendons of myostatin-deficient mice are small, brittle, and hypocellular
Mendias, C. L., Bakhurin, K. I., & Faulkner, J. A. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0707069105 · Cited by 192
Crosstalk between adipokines and myokines in fat browning
Rodríguez, A., Becerril, S., Ezquerro, S., Méndez‐Giménez, L., & Frühbeck, G. (2017) · Acta Physiologica · doi:10.1111/apha.12686 · Cited by 188
“Moreover, myostatin also inhibits the proliferation and differentiation of myoblast and satellite cells (Thomas et al. 2000, Joulia et al. 2003, McCroskery et al. 2003) and induces fibre-type switches (Mouisel et al. 2014).”
BackgroundModulation of reactive oxygen species in skeletal muscle by myostatin is mediated through NF-κB
Sriram, S., Subramanian, S., Sathiakumar, D., Venkatesh, R., Salerno, M. S., McFarlane, C. D., Kambadur, R., & Sharma, M. (2011) · Aging Cell · doi:10.1111/j.1474-9726.2011.00734.x · Cited by 189
“Myostatin is an inhibitor of myogenesis regulating both the proliferation and the differentiation of myoblasts (Thomas et al., 2000; Langley et al., 2002) and overexpression of Mstn in vivo results in cachexia in mice (Zimmers et al., 2002; ReiszPorszasz et al., 2003).”
BackgroundSelf-citationHeinemeier, K. M., Olesen, J. L., Schjerling, P., Haddad, F., Langberg, H., Baldwin, K. M., & Kjaer, M. (2007) · Journal of Applied Physiology · doi:10.1152/japplphysiol.00866.2006 · Cited by 189
“In vitro studies indicate that myostatin inhibits myoblast proliferation during myogenesis (53) as well as satellite cell activation and protein synthesis in adult mouse muscle cells (35; 52).”
BackgroundAmelioration of muscle wasting by glucagon‐like peptide‐1 receptor agonist in muscle atrophy
Hong, Y., Lee, J. H., Jeong, K. W., Choi, C. S., & Jun, H. (2019) · Journal of Cachexia, Sarcopenia and Muscle · doi:10.1002/jcsm.12434 · Cited by 188
“regulating muscle atrophy-related factors such as MuRF-1 and atrogin-1.(23) Therefore, we first determined whether Ex-4 regulates MSTN expression in C2C12 myotubes after treatment with various concentrations of Ex-4 for 6 h.”
BackgroundMuscle regeneration in the prolonged absence of myostatin
Wagner, K. R., Liu, X., Chang, X., & Allen, R. E. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0408729102 · Cited by 187
The central role of myostatin in skeletal muscle and whole body homeostasis
Elliott, B., Renshaw, D., Getting, S., & Mackenzie, R. (2012) · Acta Physiologica · doi:10.1111/j.1748-1716.2012.02423.x · Cited by 183
“C2C12 myoblasts cultured in standard growth media (Dulbecco’s modified Eagle’s media + 10% foetal bovine serum) in the presence of myostatin do not replicate, and further, this inhibition of myoblast proliferation is dose-dependent (Thomas et al. 2000, Taylor et al. 2001).”
Muscle myostatin signalling is enhanced in experimental cancer cachexia
Costelli, P., Muscaritoli, M., Bonetto, A., Penna, F., Reffo, P., Bossola, M., Bonelli, G., Doglietto, G. B., Baccino, F. M., & Fanelli, F. R. (2008) · European Journal of Clinical Investigation · doi:10.1111/j.1365-2362.2008.01970.x · Cited by 181
Sarcopenia and Age-Related Endocrine Function
Sakuma, K., & Yamaguchi, A. (2012) · International Journal of Endocrinology · doi:10.1155/2012/127362 · Cited by 179
“Since sarcopenia is largely attributed to various molecular mediators affecting fiber size, mitochondrial homeostasis, and apoptosis, numerous targets exist for drug discovery.”
BackgroundExpression of myostatin pro domain results in muscular transgenic mice
Yang, J., Ratovitski, T., Brady, J. P., Solomon, M. B., Wells, K. D., & Wall, R. J. (2001) · Molecular Reproduction and Development · doi:10.1002/mrd.1097 · Cited by 177
“Recent studies have shown that a high level of myostatin mRNA is present in fetal muscle (Bass et al., 1999), and myostatin inhibits myoblast cell proliferation in C2C12 cell culture (Thomas et al., 2000).”
Mechanisms Limiting Body Growth in Mammals
Lui, J. C., & Baron, J. (2011) · Endocrine Reviews · doi:10.1210/er.2011-0001 · Cited by 169
Proteomic analysis of bovine skeletal muscle hypertrophy
Bouley, J., Meunier, B., Chambon, C., De Smet, S., Hocquette, J. F., & Picard, B. (2005) · PROTEOMICS · doi:10.1002/pmic.200400925 · Cited by 168
Lee, S.-J., Huynh, T. V., Lee, Y.-S., Sebald, S. M., Wilcox-Adelman, S. A., Iwamori, N., Lepper, C., Matzuk, M. M., & Fan, C.-M. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1206410109 · Cited by 167
The Myostatin Gene Is a Downstream Target Gene of Basic Helix-Loop-Helix Transcription Factor MyoD
Spiller, M. P., Kambadur, R., Jeanplong, F., Thomas, M., Martyn, J. K., Bass, J. J., & Sharma, M. (2002) · Molecular and Cellular Biology · doi:10.1128/mcb.22.20.7066-7082.2002 · Cited by 166
“Myostatin is a member of the transforming growth factor superfamily, and it is well established that the myostatin gene negatively regulates muscle growth by controlling myoblast cell cycle progression (35).”
BackgroundSelf-citationMyostatin signals through Pax7 to regulate satellite cell self-renewal
McFarlane, C., Hennebry, A., Thomas, M., Plummer, E., Ling, N., Sharma, M., & Kambadur, R. (2008) · Experimental Cell Research · doi:10.1016/j.yexcr.2007.09.012 · Cited by 165
“Myoblast proliferation was assessed as described previously ( Thomas et al. 2000 ).”
BackgroundMethodInfluentialSelf-citationContractile properties of EDL and soleus muscles of myostatin-deficient mice
Mendias, C. L., Marcin, J. E., Calerdon, D. R., & Faulkner, J. A. (2006) · Journal of Applied Physiology · doi:10.1152/japplphysiol.00126.2006 · Cited by 162
Mascher, H., Tannerstedt, J., Brink-Elfegoun, T., Ekblom, B., Gustafsson, T., & Blomstrand, E. (2008) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00504.2007 · Cited by 163
“5) may promote an activation of the Akt pathway, although an alternative biological effect of reduced myostatin levels is a release of its inhibition of myoblast proliferation (30, 38).”
BackgroundMyostatin is associated with age‐related human muscle stem cell dysfunction
McKay, B. R., Ogborn, D. I., Bellamy, L. M., Tarnopolsky, M. A., & Parise, G. (2012) · The FASEB Journal · doi:10.1096/fj.11-198663 · Cited by 163
“vents progression from G1 to S phase (41).”
BackgroundMyostatin promotes the terminal differentiation of embryonic muscle progenitors
Manceau, M., Gros, J., Savage, K., Thomé, V., McPherron, A. C., Paterson, B., & Marcelle, C. (2008) · Genes & Development · doi:10.1101/gad.454408 · Cited by 186
“…mediated by cell cycle withdrawal through the activation of cdk p21 In vitro studies have shown that one of the targets of myostatin signaling is p21, a cdk inhibitor that regulates the G1/S and the G2/M transitions during cell cycle (Dulic et al. 1998; Sherr and Roberts 1999; Thomas et al. 2000).”
BackgroundInfluentialThe myostatin gene: an overview of mechanisms of action and its relevance to livestock animals
Aiello, D., Patel, K., & Lasagna, E. (2018) · Animal Genetics · doi:10.1111/age.12696 · Cited by 162
Durieux, A.-C., Amirouche, A., Banzet, S., Koulmann, N., Bonnefoy, R., Pasdeloup, M., Mouret, C., Bigard, X., Peinnequin, A., & Freyssenet, D. (2007) · Endocrinology · doi:10.1210/en.2006-1500 · Cited by 161
Physiological functions of peroxisome proliferator-activated receptor β
Neels, J. G., & Grimaldi, P. A. (2014) · Physiological Reviews · doi:10.1152/physrev.00027.2013 · Cited by 161
Miller, T. M., Kim, S. H., Yamanaka, K., Hester, M., Umapathi, P., Arnson, H., Rizo, L., Mendell, J. R., Gage, F. H., Cleveland, D. W., et al. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0609411103 · Cited by 160
The myostatin gene: physiology and pharmacological relevance
JOULIAEKAZA, D., & CABELLO, G. (2007) · Current Opinion in Pharmacology · doi:10.1016/j.coph.2006.11.011 · Cited by 161
Harmon, E. B., Apelqvist, A. A., Smart, N. G., Gu, X., Osborne, D. H., & Kim, S. K. (2004) · Development · doi:10.1242/dev.01535 · Cited by 160
“Similar short-range signaling roles have been proposed for regulation of myoblast development by GDF8, a TGF-β ligand highly homologous to GDF11, and for GDF11 in regulating neurogenesis (Lee and McPherron, 1999; Thomas et al., 2000; Wu et al., 2003).”
BackgroundDevelopmental roles of the BMP1/TLD metalloproteinases
Ge, G., & Greenspan, D. S. (2006) · Birth Defects Research Part C: Embryo Today: Reviews · doi:10.1002/bdrc.20060 · Cited by 160
Zhang, C., McFarlane, C., Lokireddy, S., Bonala, S., Ge, X., Masuda, S., Gluckman, P. D., Sharma, M., & Kambadur, R. (2011) · Diabetologia · doi:10.1007/s00125-011-2079-7 · Cited by 158
“Functionally, MSTN not only regulates the proliferation and differentiation phases of myoblast growth [7, 8], but also controls the activation and further proliferation of muscle stem cells, the satellite cells [9].”
BackgroundSelf-citationHill, E. W., McGivney, B. A., Gu, J., Whiston, R., & MacHugh, D. E. (2010) · BMC Genomics · doi:10.1186/1471-2164-11-552 · Cited by 159
“Consistent with this role myostatin has been shown to repress the proliferation and differentiation of cultured myocytes [30-32].”
BackgroundDogra, C., Changotra, H., Mohan, S., & Kumar, A. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m511131200 · Cited by 158
Engineering skeletal myoblasts: roles of three-dimensional culture and electrical stimulation
Pedrotty, D. M., Koh, J., Davis, B. H., Taylor, D. A., Wolf, P., & Niklason, L. E. (2005) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00610.2003 · Cited by 158
“For further differentiation to skeletal muscle, several other transcription factors, including myogenin, are required (34).”
BackgroundHuijing, P. A., & Jaspers, R. T. (2005) · Scandinavian Journal of Medicine and Science in Sports · doi:10.1111/j.1600-0838.2005.00457.x · Cited by 172
“Myostatin, opposing effects by the factors promoting proliferation and fusion with the hosting muscle fiber, has been identified as an inhibitor of satellite cell proliferation (Thomas et al., 2000; McCroskery et al., 2003).”
BackgroundThe two myostatin genes of Atlantic salmon (Salmo salar) are expressed in a variety of tissues
Østbye, T.-K. K., Galloway, T. F., Nielsen, C. R., Gabestad, I., Bardal, T., & Andersen, Ø. (2001) · European Journal of Biochemistry · doi:10.1046/j.0014-2956.2001.02456.x · Cited by 174
“coli, and identified in the bovine and human skeletal muscle and plasma [2,9,12].”
Background
Metadata
- Authors
- Thomas, M., Langley, B., Berry, C., Sharma, M., Kirk, S., Bass, J., & Kambadur, R.
- Affiliations
- AgResearch (NZ)
- Corresponding author
- Kambadur, Ravi
- ORCID
- Langley, Brett
- Venue
- Journal of Biological Chemistry
- Publisher
- Elsevier BV
- Published
- 2000-12
- Volume
- 275
- Issue
- 51
- Pages
- 40235-40243
- ISSN
- 0021-9258 (ISSN-L)
- OpenAlex
- W2128303661
- Semantic Scholar
- 1d23c762e638a24e032fb334a031fafce76bc3ab
- Cited by
- 1,014
- References
- 34
- Citations by year
- 2026: 17 · 2025: 31 · 2024: 21 · 2023: 33 · 2022: 35 · 2021: 39 · 2020: 33 · 2019: 37 · 2018: 33 · 2017: 40 · 2016: 46 · 2015: 38 · 2014: 52 · 2013: 58 · 2012: 55
- FWCI
- 8.91
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- cc-by
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
- creativecommons.org/licenses/by/4.0/ (vor, 7240 d)
- Locations
- Journal of Biological Chemistry (publishedVersion, cc-by)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Muscle Physiology and Disorders
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › TGF-β signaling in diseases
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Developmental Biology and Gene Regulation
- Keywords
- myostatin, myoblast proliferation, muscle growth, myogenesis, G1 cell cycle arrest, p21, CDK2, retinoblastoma protein, C2C12 myoblasts, TGF-beta superfamily, muscle precursor cells
- MeSH terms
- Animals, Base Sequence, Cattle, Cell Cycle, Cell Division, Cells, Cultured, Hydrolysis, Phosphorylation, Retinoblastoma Protein, Transforming Growth Factor beta, DNA Primers, Muscle, Skeletal, Myostatin
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.